26 May 2013
Keywords: bayer, avelox, approved, csssi, eu, germany, healthcare
Article | 15 August 2005
Germany's Bayer HealthCare says that its prescription antibiotic Avelox IV (moxifloxacin HCl, solution for infusion) has been approved for the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 August 2005
24 May 2013
© 2013 thepharmaletter.com